Company snapshot
Market Cap
$45B
Large-cap2016 — today
10-Year Price
+383%
2016 — today
52-Week Range
$504.70$766.68
Current $562.91· 22%
Featured in rankings
S&P500NASDAQMost Undervalued Healthcare StocksMost Undervalued Value StocksMost Undervalued Growth StocksCheapest Large-Cap Stocks
Rankings recomputed after each US market close — see where IDXX stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| TEVATeva Pharmaceutical Industries Limited | 66.6 | — |
| ONCBeOne Medicines Ltd. | 5.2 | — |
| HUMHumana Inc. | 39.0 | 0.6% |
| AAgilent Technologies, Inc. | 35.7 | 0.4% |
| RVMDRevolution Medicines, Inc. | -21.3 | — |
| EWEdwards Lifesciences Corporation | 52.7 | — |
| BDXBecton, Dickinson and Company | 58.8 | 2.0% |
| ARGXargenx SE | 22.1 | — |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
39.9
Near historic low
Near historic low — last 10 years
Sector median 24.1above sector
P/B ratio
28.2
Below average
Below the 10-year average
Sector median 2.3above sector
EV / EBITDA
28.6
Near historic low
Near historic low — last 10 years
Sector median 15.0above sector
PEG ratio
3.9
Historically pricey
Historically pricey — last 10 years
Sector median 1.7above sector
FCF Yield
2.8%
Near historic high
Near historic highs — last 10 years
Sector median -12.4%above sector